White Brook Capital Partners: Stocks We Believe Will Be Meaningful Contributors
Summarize this article with:
White Brook Capital10 FollowersFollow5ShareSavePlay(8min)CommentsSummaryICON trades at a low double digit multiple of free cash flow, a fraction of its historical average and a price that materially underestimates the strength of their business.Growth and tumult in private credit, data center financing, and AI driven financial engineering products reinforce the necessity of S&P Global's services.Sanara Medtech continues to be an extremely favorable risk reward with increasing evidence of their product's efficacy recently released and a focus on increasing per hospital doctor penetration.Rapid Micro Biosystems is well positioned and represents the best risk reward in the portfolio given increasing business momentum with significant early rollouts with major partners. 1550539/iStock via Getty Images The following segment was excerpted from the White Brook Capital Partners Q1 2026 Commentary.
Individual Stock Updates: Icon Public Limited Company (ICLR) ($ICLR) is a global contract drug manufacturing company we've followed for some timeThis article was written byWhite Brook Capital10 FollowersFollowWhite Brook Capital LLC is a socially responsible, investment advisory firm founded in 2016, based in Chicago. The Company invests separately managed accounts and manages the White Brook Capital Partners fund for qualified investors. Note: This account is not managed or monitored by White Brook Capital , and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use White Brook Capital's official channels.